The effects of lowering uric acid levels using allopurinol on components of Metabolic Syndrome.

dc.contributor.advisorBowden, Rodney G., 1966-
dc.contributor.authorHeimbach, Esther J.
dc.contributor.departmentHealth, Human Performance and Recreation.en
dc.contributor.otherBaylor University. Dept. of Health, Human Performance and Recreation.en
dc.date.accessioned2011-05-12T15:36:27Z
dc.date.available2011-05-12T15:36:27Z
dc.date.copyright2011-05
dc.date.issued2011-05-12T15:36:27Z
dc.description.abstractPurpose: To determine the relationship between uric acid and lipid levels for the purpose of understanding more about the public health issue of Metabolic Syndrome. Methods: A retrospective analysis was conducted using 66 patients from a family health clinic who were over the age of 18 and who had been given at least three prescriptions of allopurinol. Repeated measures linear growth models with Restricted Maximum Likelihood tests were conducted to determine the relationship of uric acid and the lipid levels. Results: A significant relationship between uric acid and lipid levels was not determined. There was a slight indication of a relationship between uric acid and total cholesterol or HDL-cholesterol. Uric acid levels did not decrease over time for all participants as expected. Conclusions: More research is needed to explore the relationship between uric acid and lipid levels. Furthermore, compliance among participants could be enhanced by determining best health education methods.en
dc.description.degreeM.P.H.en
dc.description.statementofresponsibilityby Esther J. Heimbach.en
dc.format.extent63798 bytes
dc.format.extent3008868 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.identifier.urihttp://hdl.handle.net/2104/8145
dc.language.isoen_USen
dc.rightsBaylor University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact librarywebmaster@baylor.edu for inquiries about permission.en
dc.rights.accessrightsWorldwide access.en
dc.rights.accessrightsAccess changed 9/12/13.
dc.subjectUric acid.en
dc.subjectMetabolic Syndrome.en
dc.subjectAllopurinol.en
dc.subjectTriglycerides.en
dc.subjectHDL-cholesterol.en
dc.subjectLDL-cholesterol.en
dc.subjectTotal cholesterol.en
dc.subjectHyperuricemia.en
dc.subjectPublic health.en
dc.subjectLipid levels.en
dc.titleThe effects of lowering uric acid levels using allopurinol on components of Metabolic Syndrome.en
dc.typeThesisen

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Esther_Heimbach_masters.pdf
Size:
2.87 MB
Format:
Adobe Portable Document Format
Description:
Thesis
No Thumbnail Available
Name:
Esther_Heimbach_permissions.pdf
Size:
62.3 KB
Format:
Adobe Portable Document Format
Description:
Permissions Form

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.96 KB
Format:
Item-specific license agreed upon to submission
Description: